Day: September 28, 2020

Hermed indkaldes til ekstraordinær generalforsamling tirsdag den 27. oktober 2020 kl. 10.00 i Kulturcenter Limfjord.  Indkaldelse til og dagsorden for generalforsamlingen er vedlagt denne meddelelse. Bankens selskabsmeddelelser kan ses på bankens hjemmeside www.sallingbank.dk.Vedhæftet fil2020 nr. 11 Indkaldelse ekstraordinær GF 2020 bilag

VANCOUVER, British Columbia, Sept. 28, 2020 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce it will host a webinar today at 11am EDT (8am Pacific; 4pm UK), following the release of the results of a high resolution, drone mounted, magnetic survey (the “Survey”) in the district surrounding the Company’s flagship Marimaca Copper Project (“Marimaca” or “the Project”) in Chile.Questions can be submitted through the webinar platform, or via email to marimaca@tavistock.co.uk no later than two hours prior to the scheduled start time.To access the webinar please click on the link below:Webinar LinkThe Survey has identified several large-scale magnetic anomalies which the Company believes are prospective for Marimaca IOCG style deposits.HighlightsFour large scale magnetic anomalies...

PITTSBURGH, Sept. 28, 2020 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the Chardan Virtual 4TH Annual Genetic Medicines Conference being held on October 5 – 6.About NeuBase TherapeuticsNeuBase is accelerating the genetic revolution using a new class of synthetic medicines. NeuBase’s designer PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the source by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus...

CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at Chardan’s Virtual 4th Annual Genetic Medicines Conference on Monday, October 5, 2020 at 9 a.m. ET.A live webcast of Intellia’s presentation will be accessible through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com. To access the webcast, please log on approximately 15 minutes prior to the start time, to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for approximately 14 days following the live event.Intellia Contacts:Investors:Lina LiAssociate...

HERNDON, Va., Sept. 28, 2020 (GLOBE NEWSWIRE) — ManTech International Corporation (Nasdaq: MANT) will issue its third quarter fiscal year 2020 earnings press release after close of market Thursday, November 5, 2020. Management will discuss financial results in a conference call beginning at 5 p.m. ET.Analysts may participate in the conference call by dialing (877) 638-9567 (domestic) or (253) 237-1032 (international) and entering pass code 8546935. The conference call will be webcast simultaneously to the public through a link on the Investor Relations section of the ManTech website (http://investor.mantech.com). A replay of the conference call will be available on the ManTech website approximately 2 hours after the conclusion of the call.About ManTech International CorporationManTech provides mission-focused technology solutions...

COLORADO SPRINGS, CO, Sept. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Gold Resource Corporation (NYSE American: GORO) (the “Company”) declares its monthly instituted dividend of one-third of a cent per common share for September 2020 payable on October 23, 2020 to shareholders of record as of October 12, 2020.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA.  The Company has returned $115 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery.  For more information on Gold Resource Corporation’s physical dividend program, visit the Company website at http://www.goldresourcecorp.com/gold-silver-dividends.php.   Dividends...

QUEBEC CITY, Sept. 28, 2020 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to announce that Utility Partners, LLC (“UP”), its business line dedicated to operation and maintenance services (“O&M”) in North America, has recently been awarded a new O&M contract and renewed an existing project. These contracts, with a total value of $5.1 M, bring the O&M backlog to $84.9 M.The first contract won is for the operation and maintenance services of a municipality in Florida, for a period of three (3) years. A total of 20 employees will be added to operate this infrastructure. This contract will start on October 1st, 2020 and consist of water distribution, sewers and storm water collection, and natural gas operation. Over the years, the Corporation has delivered more...

QUÉBEC, 28 sept. 2020 (GLOBE NEWSWIRE) — (TSXV : HEO) – H2O Innovation inc. (« H2O Innovation » ou la « Société ») a le plaisir d’annoncer qu’Utility Partners, LLC (« UP »), sa ligne d’affaires dédiée aux services d’opération et maintenance (« O&M ») en Amérique du Nord, a récemment remporté un nouveau contrat d’O&M et renouvèle un projet existant. Ces contrats, d’une valeur totale de 5,1 M $, portent le carnet de commandes d’O&M à 84,9 M $.Le premier contrat remporté consiste en des services d’opération et maintenance pour une municipalité en Floride, et ce, pour une durée de trois (3) ans. Un total de 20 employés seront ajoutés pour opérer cette infrastructure. Ce dernier commencera le 1er octobre prochain et consistera en la distribution d’eau, la collection des égouts et des eaux pluviales et l’opération du réseau...

NEENAH, Wis., Sept. 28, 2020 (GLOBE NEWSWIRE) — Plexus (NASDAQ: PLXS) announced today its partnership with Quidel Corporation (“Quidel”) in support of the Sofia®2 Fluorescent Immunoassay Analyzer. Plexus will provide Supply Chain and Manufacturing Solutions to Quidel, an industry leader in diagnostic healthcare. The two companies will collaborate to scale the Sofia®2 product in order to support increased demand for point-of-care testing used in the fight against COVID-19.Sofia®2 is Quidel’s best-selling cartridge-based rapid diagnostic system for infectious disease testing. It is a small bench top analyzer that can be used near patients and in laboratory settings. Sofia® 2 has the power to deliver fast, highly accurate, objective and automated results, in 15 minutes or less, that aid in the diagnosis of many critical diseases and...